Treatment Action Group is an independent AIDS research and policy think tank fighting for better treatment, a vaccine, and a cure for AIDS. TAG works to ensure that all people with HIV receive life saving treatment, care, and information. [ TAG's mission statement ]

more about TAG • TAG at ten • annual reports • board of directors • staff • donations

Donor Appeal Letter May 2007 accompanies TAG Annual Report 2007 and TAG in the News, 2007

TAG's work on basic science advocacy is devoted to speeding the conduct of research on the pathogenesis of HIV infection (how the AIDS virus causes disease) and the interactions between the virus and the immune system. We believe that a greater understanding in these areas will pave the way for better treatments for HIV infection and an eventual vaccine to protect against HIV transmission. TAG accomplishes its advocacy work by providing analyses of the scientific and practical impediments that slow the progress of basic research, offering recommendations to expedite progress and pushing for the adoption of these measures.

◊ Vaccines and Immune Based Therapies
TAG also works to speed our progress towards the development of a vaccine against HIV transmission and immune based therapies for people with HIV. We work with industry and government sponsors of research in this area to push for more and better research, offering recommendations for change based on analyses of ongoing efforts.

◊ Michael Palm HIV Pathogenesis and Prevention Research Project Grant
TAG has been awarded a four-year project grant to strengthen efforts to accelerate search for immune-based HIV therapies, vaccines, microbides, and a cure. Press release | Palm Donor Circle

TAG advocates for responsible public policy on AIDS research and treatment with our nation's leaders, including members of Congress and officials from the relevant agencies in the Executive Branch. We push for more funding for AIDS research and sensible legislative initiatives to foster better biomedical research. TAG also advocates for sound regulatory policy in the evaluation of AIDS drugs which balances the need for access to new agents and the need for reliable information about their clinical efficacy.

TAG closely monitors HIV antiretroviral drugs in all stages of development, including post-marketing. We advocate for the expeditious development, proper clinical research and regulation, ease of access and optimal use of these drugs. We work with other treatment activists and researchers, FDA, NIH, and the pharmaceutical industry to achieve these objectives. TAG also helps educate members of the HIV community about antiretrovirals.

TAG closely monitors new data on the epidemiology and natural history of HIV/HCV coinfection and HIV/TB coinfection, as well as the development of new diagnostics, prophylaxis and treatments for hepatitis C and tuberculosis, in both the pre- and postmarketing stages. We advocate for the expeditious development, proper clinical research and regulation, ease of access and optimal use of these drugs. We work with the pharmaceutical companies, NIH, FDA, researchers and other treatment activists to achieve these objectives. TAG also educates members of the HIV community about coinfection with hepatitis C and tuberculosis.

The Project works to combat TB/HIV co-infection through a combination of community-based advocacy, education and mobilization efforts involving AIDS advocates in developed and developing countries. The TB/HIV Project is supported by a grant from the Bill & Melinda Gates Foundation.

Would you like to receive TAGline at your home or office?
A one-year subscription is $30 for individuals, $50 for institutions.
(Subscription is automatic for anyone making annual donations to TAG at or above these amounts.)

Print/fax or submit the subscription form :

or send your check or money order, payable to Treatment Action Group, to us at:<

Treatment Action Group
611 Broadway, Ste. 308
New York, NY 10012-2608

(212) 253-7922 phone
(212) 253-7923 fax
tagnyc@verizon.net

Donations can also be made through our link with PayPal.